Narrative review / 2006
Deficiencies in carnitine transport and the carnitine cycle cause distinct metabolic crises that respond to carnitine and low-fat diets with medium chain fats.
This review describes disorders affecting the transfer of long-chain fatty acids into mitochondria, including OCTN2, CPT1, CACT, and CPT2 deficiencies. Primary carnitine deficiency from OCTN2 transporter defects leads to urinary carnitine loss and reduced tissue accumulation, presenting with hypoketotic hypoglycemia, hepatic encephalopathy, or skeletal/cardiac myopathy, and responds to carnitine supplementation. Deficiencies in CPT1, CACT, and CPT2 cause varied presentations including neonatal hypoglycemia, hyperammonemia, cardiomyopathy, or exercise-induced rhabdomyolysis. Management for CPT1, CPT2, and CACT deficiencies includes a low-fat diet supplemented with medium chain triglycerides, carnitine supplements, and avoiding fasting and sustained exercise.
- Study type
- Narrative review
- Who was studied
- Patients with disorders of carnitine transport and the carnitine cycle
- What was measured
- Clinical presentation and management of carnitine-related metabolic disorders
THE PAPER
Disorders of carnitine transport and the carnitine cycle.
Longo N, Amat di San Filippo C, Pasquali M. Am J Med Genet C Semin Med Genet, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.